Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer

被引：8

作者：

Choe, Jooae ^{[1
,2
]}

Braschi-Amirfarzan, Marta ^{[3
,4
]}

Tirumani, Sree Harsha ^{[4
]}

Shinagare, Atul B. ^{[3
,4
]}

Kim, Kyung Won ^{[1
,2
]}

Ramaiya, Nikhil H. ^{[3
,4
]}

Krajewski, Katherine M. ^{[3
,4
]}

机构：

[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, 86 Asanbyeongwon Gil, Seoul 138736, South Korea

[2] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, 86 Asanbyeongwon Gil, Seoul 138736, South Korea

[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Imaging, 450 Brookline Ave, Boston, MA 02215 USA

[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA

来源：

ABDOMINAL RADIOLOGY | 2017年 / 42卷 / 11期

关键词：

Bladder cancer; Urothelial carcinoma; Diagnosis; Management; Oncologic imaging; COMPUTED-TOMOGRAPHY UROGRAPHY; GEMCITABINE PLUS CISPLATIN; URINARY-BLADDER; UROTHELIAL CARCINOMA; RADICAL CYSTECTOMY; MDCT UROGRAPHY; CT UROGRAPHY; LYMPH-NODES; FOLLOW-UP; RECURRENCE;

D O I：

10.1007/s00261-017-1195-3

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Urothelial bladder cancer is a common malignancy requiring a multidisciplinary approach to treatment. Significant recent advances have been made in terms of the genetic and molecular characterization of bladder cancer subtypes, and novel treatment approaches are being investigated and approved. Given the important role of imaging in the diagnosis, staging, and follow-up of this disease, it is necessary for radiologists to remain up-to-date in terms of nomenclature and standards of care. In this review, recent developments in bladder cancer characterization and treatment will be discussed, with reference to the contributions of imaging in non-muscle-invasive, muscle-invasive, and metastatic settings.

引用

页码：2710 / 2724

页数：15

共 50 条

[41] Non-muscle-invasive bladder cancer: a vision for the future
Malmstrom, Per-Uno
Agrawal, Sachin
Blackberg, Mats
Bostrom, Peter J.
Malavaud, Bernard
Zaak, Dirk
Hermann, Gregers G.
SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 (02) : 87 - 94
[42] Management of Non-Muscle-Invasive (Superficial) Bladder Cancer
Nargund, Vinod H.
Tanabalan, C. K.
Kabir, M. N.
SEMINARS IN ONCOLOGY, 2012, 39 (05) : 559 - 572
[43] Mutational landscape of non-muscle-invasive bladder cancer
Hurst, Carolyn D.
Knowles, Margaret A.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (07) : 295 - 303
[44] Current management of non-muscle-invasive bladder cancer
Rodriguez Faba, O.
Gaya, J. M.
Lopez, J. M.
Capell, M.
De Gracia-Nieto, A. E.
Gomez Correa, E.
Breda, A.
Palou, J.
MINERVA MEDICA, 2013, 104 (03) : 273 - 286
[45] Intravesical chemotherapy in non-muscle-invasive bladder cancer
Porten, Sima P.
Leapman, Michael S.
Greene, Kirsten L.
INDIAN JOURNAL OF UROLOGY, 2015, 31 (04) : 297 - 303
[46] Guideline of guidelines: non-muscle-invasive bladder cancer
Woldu, Solomon L.
Bagrodia, Aditya
Lotan, Yair
BJU INTERNATIONAL, 2017, 119 (03) : 371 - 380
[47] New therapies for non-muscle-invasive bladder cancer
Chiong, Edmund
Esuvaranathan, Kesavan
WORLD JOURNAL OF UROLOGY, 2010, 28 (01) : 71 - 78
[48] Usefulness of neoadjuvant chemotherapy in non-metastatic muscle-invasive bladder cancer
Esper Rueda, J. A.
Carrion Lopez, P.
Donate Moreno, M. J.
Herais Raya, L.
Sanchez Migallon, I. Diaz de Mera
Legido Gomez, O.
Rico Marco, S.
Martinez Ruiz, J.
Nogueron Martinez, E.
Salinas Sanchez, A. S.
ACTAS UROLOGICAS ESPANOLAS, 2021, 45 (04): : 300 - 308
[49] Re: EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
de Jong, Joep J.
Lotan, Yair
Boormans, Joost L.
EUROPEAN UROLOGY, 2024, 86 (05) : 480 - 481
[50] Chemotherapy for Muscle-Invasive Bladder Cancer
Patrizia Trenta
Fabio Calabrò
Linda Cerbone
Cora N. Sternberg
Current Treatment Options in Oncology, 2016, 17

← 1 2 3 4 5 →